Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women) in Kenya was reported at 34.7 % in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources. Kenya - Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
 kenya use of intermittent preventive treatment of malaria 2 doses of sp fansidar percent of pregnant women wb data


Percentage of women with a live birth in the recent years preceding the survey who received 2+ doses of sulfadoxine-pyrimethamine (SP/Fansidar), at least one during an antenatal care visit. Intermittent Preventive Treatment (IPT) is preventive treatment with SP/Fansidar during an antenatal care (ANC) visit treatment with a dose of sulfadoxine-pyrimethamine (SP/Fansidar) to pregnant women at each scheduled antenatal visit after the first trimester, but not more frequently than once a month.


Kenya | World Bank Development Indicators